Related Experiment Video
Updated: Jun 29, 2025
09:03
Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
924
Prostanoids Regulate Angiogenesis and Lymphangiogenesis in Pathological Conditions.
Masataka Majima1,2,3, Yasuhiro Matsuda4, Shin-Ichi Watanabe5
1Department of Medical Therapeutics, Kanagawa Institute of Technology, 1030 Shimo-Ogino, Atsugi, Kanagawa 243-0292, Japan mmajima@cet.kanagawa-it.ac.jp.
Cold Spring Harbor Perspectives in Medicine
|April 2, 2024
Summary
Prostaglandin E-type receptor 3 (EP3) signaling is crucial for tumor angiogenesis and lymphangiogenesis, impacting wound healing and cancer progression. Targeting EP3 signaling offers a potential therapeutic strategy for related diseases.
Area of Science:
- Biomedical Science
- Molecular Biology
- Oncology
Background:
- Angiogenesis is vital for wound repair and tumor growth.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostanoid biosynthesis, affecting cancer and wound healing, but mechanisms are unclear.
- Prostanoid signaling extends beyond smooth muscle contraction and vasoactivity.
Purpose of the Study:
- To elucidate the precise mechanisms by which prostanoid signaling influences angiogenesis and lymphangiogenesis.
- To investigate the role of prostaglandin E-type receptor signaling in tumor angiogenesis and pathological lymphangiogenesis.
Main Methods:
- Utilized prostanoid receptor knockout mouse models.
- Analyzed the induction of vascular endothelial growth factor A (VEGF-A) and VEGF-C/D.
Main Results:
- Prostaglandin E-type receptor 3 (EP3) signaling in the host microenvironment is critical for tumor angiogenesis by inducing VEGF-A.
- EP signaling enhances lymphangiogenesis via VEGF-C/D induction in pathological conditions.
- EP receptors play a significant role in facilitating angiogenesis and lymphangiogenesis in vivo.
Conclusions:
- Prostanoid receptor signaling, particularly EP3, is a key driver of angiogenesis and lymphangiogenesis.
- EP receptor signaling represents a potential therapeutic target for diseases involving aberrant angiogenesis and lymphangiogenesis.
- Understanding prostanoid receptor roles offers new avenues for treating cancer and impaired wound healing.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:10Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
173
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
173
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K